CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 260 enrolled
Drug / intervention
PENNSAID Gel +1 moredrug
Likely dose
PENNSAID Gel 2 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01119898
NCT01119898Phase 2Completed
CompareCT.gov

A Phase 2, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Clinical Study to Evaluate the Safety and Efficacy of PENNSAID Gel in the Symptomatic Treatment of Osteoarthritis of the Knee

Mallinckrodt·interventional·Posted May 10, 2010·Updated Oct 22, 2019

In Brief

A Phase 2 clinical trial evaluating PENNSAID Gel and Vehicle for Osteoarthritis of the Knee. Completed, enrolled 260 participants across 26 sites.

Detailed Summary

Osteoarthritis (OA) is the most common form of arthritis. It can cause pain, swelling, and reduced motion in the joints. That can reduce quality of life. OA can occur in any joint, but usually affects the hands, knees, hips or spine. The purpose of this study is to find out if doctors might be able to use 2% PENNSAID gel to treat OA in the knee.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis of the Knee
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 10, 2010
Enrollment StartAug 2, 2010
Primary CompletionFeb 16, 2011
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 16.1 years ago

Interventions

PENNSAID Geldrug

2 mL applied to the front, back and sides of the knee twice a day (morning and night) for 4 weeks

Vehicledrug

2 mL applied to the front, back and sides of the knee twice a day (morning and night) for 4 weeks